Search bioRxiv⌕ Search

bioRxiv · 10.1101/2024.12.16.628598

Ultraviolet B Induces Cutaneous Lupus Erythematosus by Triggering a Ribotoxic-Stress-Response-Dependent MIF-p38 Feedback Loop in Keratinocytes

Abstract

Ultraviolet B (UVB) is one of the most common triggers of cutaneous lupus erythematosus (CLE), but the mechanism is still unclear. Here, we discovered that the expression of macrophage migration inhibitory factor (MIF), a multipotent cytokine, was significantly increased in keratinocytes of lupus patients in scRNA-seq data and clinical samples. We further discovered that UVB exposure induced MIF releasing from lupus keratinocytes and contributed to the tissue remodeling and inflammation by regulating the expression of matrix metalloproteinases (MMPs) and pro-inflammatory cytokines in keratinocytes and fibroblasts. Mechanistically, UVB exposure triggered a ribotoxic stress response (RSR) in lupus keratinocytes, which was featured by the increased level of phospho-ZAK. The RSR induced MIF releasing through the activation of p38 and GSDMD cleavage. The released MIF could further promote the activation of p38 through its receptor CD74, forming a positive feedback loop triggered by UVB exposure in lupus keratinocytes. Intradermal injection of a Mif-shRNA AAV significantly improved the skin lesions in lupus mice. To further investigate the potentials of MIF as a therapeutic target, we developed a microneedle patch capable of intradermal administration of a MIF inhibitor, which effectively protected lupus mice from skin lesions induced by UVB exposure. In conclusion, our findings suggest a novel mechanism by which UVB exposure contributes to the development of CLE by triggering a positive feedback loop of MIF-p38 in lupus keratinocytes. Our results also demonstrate the translational potentials of microneedle patch targeting MIF in the treatment of CLE.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Guo, C., Luo, S., Luo, J., Lv, H., Zhang, Y., Wang, L., Liu, T., Zhou, Y.. 2025-01-03. Ultraviolet B Induces Cutaneous Lupus Erythematosus by Triggering a Ribotoxic-Stress-Response-Dependent MIF-p38 Feedback Loop in Keratinocytes. https://doi.org/10.1101/2024.12.16.628598

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Common viral infections seed regionally distinct resident memory T cells in the human CNS

T cells persist in the central nervous system (CNS) and can drive both protection and neurological disease. How these cells are organized in humans and what they recognize is largely unknown. Here, we profiled CD8 T cells across anatomically distinct CNS regions, obtained through on-site autopsies and temporal lobe resection surgeries, using single-cell RNA sequencing, paired T cell receptor sequencing, and DNA-barcoded tetramers. Resident memory T cells (TRM) specific for Epstein-Barr virus, cytomegalovirus, influenza A, and SARS-CoV-2 were identified across CNS compartments. Anatomical location was the strongest correlate of TRM cell state, with leptomeningeal cells adopting a cytokine-poised TRM program, whereas brain TRM cells were transcriptionally restrained. Cells of the same clonotype spanned tissues yet adopted local transcriptional states. Viral specificity added another layer of TRM heterogeneity with GZMK/GZMA-expressing EBV-specific populations and interferon-stimulated gene signatures in SARS-CoV-2 and Influenza A-specific cells. The human CNS thus harbors regionally distinct CD8+ TRM shaped by common viral exposures.

immunology↗

A regulatory T cell signature provides a shared molecular basis for the therapeutic window of opportunity in rheumatic disease

Rheumatic diseases, including rheumatoid arthritis (RA), spondyloarthritis (SpA) and osteoarthritis (OA), show distinct phenotypes yet respond to overlapping therapies, implicating shared immune mechanisms. In the Transimmunom cohort, we profiled peripheral blood from 240 individuals (47 healthy, 44 OA, 91 RA, 58 SpA) across deep immunophenotyping, immunoproteomics and Treg-Teff transcriptomics. Single-layer analyses revealed broader Treg than Teff remodeling, along with a shared pattern of reduced activated Tregs and expanded Helios+ Tregs across all diseases, alongside a decrease in functional Treg subpopulations, including CTLA4+ and CD45RA- Tregs. In RA specifically, LAG3+ Tregs were also expanded. Combining omics layers outperformed single-layer approaches for disease classification. Among individual layers, Treg transcriptomes were most discriminative, and integration uncovered disease-specific programs. Unsupervised clustering identified a cross-disease cluster independent of activity, treatment and age, mapping to early disease (<= years) and dominated by a Treg dysfunction-associated program. These results provide a biological rationale for the therapeutic "window of opportunity" concept and duration-stratified Treg-directed trials.

immunology↗

Inhibitory Fc Receptor sets a time limit on macrophage response to IgG

Antibodies engage both activating Fc Receptors and the inhibitory receptor Fc{gamma}RIIB. Why macrophages need a dedicated inhibitory receptor rather than simply tuning activating receptor signaling is unclear. Using DNA-based chimeric receptors and in silico modeling, we independently controlled activating and inhibitory Fc Receptors. We found that Fc{gamma}RIIB imposed a time limit on macrophage phagocytosis and ERK signaling. The time limit is due to activating Fc Receptors converting PI(4,5)P2 to PI(3,4,5)P3, which is subsequently converted to PI(3,4)P2 by Fc{gamma}RIIB. This leads to a pulse of active signaling, which is sufficient for phagocytosis of small bacteria-sized targets but not phagocytosis of large targets and TNF secretion. Unlike engaging Fc{gamma}RIIB, reducing activating Fc Receptor signaling decreased initiation of phagocytosis, the speed of PI(3,4,5)P3 generation, and the amplitude of ERK signaling. Our results demonstrate that Fc{gamma}RIIB controls the duration of IgG signaling, while the activating Fc Receptors control sensitivity.

immunology↗